查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1888646

小分子医疗保健契约製造市场规模、份额和趋势分析报告：按服务、治疗领域、地区和细分市场预测（2025-2033 年）

Small Molecule Healthcare Contract Manufacturing Market Size, Share & Trends Analysis Report By Service (API, Finished Drug Product), By Therapeutic Area, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

小分子医疗保健契约製造市场摘要

2024年全球小分子医疗保健契约製造市场规模估计为1,090.4亿美元，预计到2033年将达到3,106亿美元。

预计从 2025 年到 2033 年，该市场将以 12.56% 的复合年增长率成长。推动该市场成长的关键因素包括对成本效益高的药物生产的需求不断增长、小分子治疗药物研发管线不断扩大，以及製药公司将生产营运外包以专注于研发和商业化等核心活动的趋势日益增长。

此外，製药公司为降低营运成本、提高柔软性并加快产品上市速度而日益增加的生产活动外包，也推动了市场的发展。由于新型小分子药物的研发和商业化需要大量的资本投入和专门的基础设施，企业越来越多地转向契约製造组织（CMO）以简化生产流程。对学名药日益增长的需求，以及针对癌症、心血管疾病和糖尿病等慢性疾病的药物研发管线不断扩大，进一步推动了对可扩展、高品质生产服务的需求。

此外，製程化学、分析方法和连续生产技术的进步进一步提高了小分子药物的生产效率和产量。对高活性药物原料药（HPAPI）和复杂製剂日益增长的需求也促使製药公司与拥有先进防护技术和法规能力的专业合约研发生产机构（CDMO）合作。

目录

第一章调查方法和范围

第二章执行摘要

3. 小分子医疗保健契约製造市场：变数、趋势和范围

  • 市场发展前景
  • 小分子医疗保健契约製造市场的市场动态
  • 技术展望
  • 定价模式分析
  • 关税影响分析
  • 供应链分析
  • 市场分析工具

第四章 小分子医疗保健契约製造市场：按服务类型分類的估算与趋势分析

  • 全球小分子医疗保健契约製造市场波动分析（按服务类型划分）
  • 全球小分子医疗保健契约製造市场规模及趋势分析（按服务类型划分，2021-2033 年）
  • 活性药物成分（API）
  • 开发和规模化服务
  • 最终剂型
  • 包装

第五章 小分子医疗保健契约製造市场：按治疗领域分類的估算与趋势分析

  • 全球小分子医疗保健契约製造市场按治疗领域分析
  • 全球小分子医疗保健契约製造市场规模及趋势分析（依治疗领域划分，2021-2033年）
  • 肿瘤学
  • 心血管疾病
  • 神经系统疾病
  • 感染疾病
  • 整形外科疾病
  • 代谢性疾病
  • 自体免疫疾病
  • 消化系统疾病
  • 呼吸系统疾病
  • 眼科
  • 牙科疾病
  • 其他的

6. 小分子医疗保健契约製造市场：按最终用途分類的估算和趋势分析

  • 全球小分子医疗保健契约製造市场最终用途波动分析
  • 全球小分子医疗保健契约製造市场规模及趋势分析（按最终用途划分），2021-2033年
  • 製药公司
  • 生技公司
  • 其他的

第七章 小分子医疗保健契约製造市场：按服务和应用分類的估算和趋势分析

  • 区域市场概览
  • 全球市场概览（按地区划分）
  • 市场规模、预测与趋势分析（2021-2033）：
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特
    • 阿曼
    • 卡达

第八章 竞争情势

  • 公司分类
    • 市场领导
    • 新兴企业
  • 小分子医疗保健契约製造市场分析，2024 年
  • 公司简介
    • Lonza Group
    • Catalent Inc.
    • Recipharm AB
    • Thermo Fisher Scientific Inc.
    • WuXi AppTec
    • Cambrex Corporation
    • Eurofins Scientific
    • Siegfried Holding AG
    • CordenPharma
    • PCI Pharma Services
Product Code: GVR-4-68040-802-2

Small Molecule Healthcare Contract Manufacturing Market Summary

The global small molecule healthcare contract manufacturing market size was estimated at USD 109.04 billion in 2024 and is projected to reach USD 310.6 billion by 2033, growing at a CAGR of 12.56% from 2025 to 2033. The market growth is driven by the increasing demand for cost-efficient drug production, the expanding pipeline of small molecule therapeutics, and the rising trend of outsourcing among pharmaceutical companies to focus on core competencies such as R&D and commercialization.

In addition, the market is driven by the rising outsourcing of manufacturing activities by pharmaceutical companies seeking to reduce operational costs, enhance flexibility, and accelerate time-to-market. Developing and commercializing new small-molecule drugs requires significant capital investment and specialized infrastructure, prompting companies to rely on contract manufacturing organizations (CMOs) for production efficiency. The increasing demand for generic and branded small molecule drugs, coupled with the expanding pipeline of therapeutics targeting chronic diseases such as cancer, cardiovascular disorders, and diabetes, is further boosting the need for scalable, high-quality manufacturing services.

Furthermore, technological advancements in process chemistry, analytical methods, and continuous manufacturing are further enhancing production efficiency and yield in small molecule manufacturing. The growing focus on high-potency active pharmaceutical ingredients (HPAPIs) and complex formulations has also encouraged pharmaceutical companies to partner with specialized CDMOs that possess advanced containment and regulatory capabilities.

Global Small Molecule Healthcare Contract Manufacturing Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global small molecule healthcare contract manufacturing market report based on phase, service, therapeutic area, end use, and region:

  • Service Outlook (Revenue, USD Million, 2021 - 2033)
  • API
  • Development & Scale-up Services
  • Finished dose formulations
  • Packaging
  • Therapeutic Area Outlook (Revenue, USD Million, 2021 - 2033)
  • Oncology
  • Cardiovascular Disease
  • Neurological Disorders
  • Infectious Diseases
  • Orthopedic Diseases
  • Metabolic Disorders
  • Autoimmune Diseases
  • Gastrointestinal Disorders
  • Respiratory Diseases
  • Ophthalmology
  • Dental Diseases
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Pharmaceutical Companies
  • Biotechnology Companies
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Norway
    • Sweden
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
    • Oman
    • Qatar

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Value chain based analysis (Model 2)
    • 1.7.3. Multivariate Analysis (Model 3)
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Landscape Insights

Chapter 3. Small Molecule Healthcare Contract Manufacturing Market: Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Ancillary Market Outlook
  • 3.2. Small Molecule Healthcare Contract Manufacturing Market Dynamics
    • 3.2.1. Market Driver Impact Analysis
    • 3.2.2. Market Restraint Analysis
    • 3.2.3. Market Opportunities
  • 3.3. Technological Landscape
  • 3.4. Pricing Model Analysis
  • 3.5. Tariff Impact Analysis
  • 3.6. Supply Chain Analysis
  • 3.7. Market Analysis Tools
    • 3.7.1. Porter's Five Forces Analysis
    • 3.7.2. PESTEL by SWOT Analysis

Chapter 4. Small Molecule Healthcare Contract Manufacturing Market: Service Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Small Molecule Healthcare Contract Manufacturing Market Service Movement Analysis
  • 4.3. Global Small Molecule Healthcare Contract Manufacturing Market Size & Trend Analysis, by Service, 2021 to 2033 (USD Million)
  • 4.4. Active Pharmaceutical Ingredient (API)
    • 4.4.1. Active Pharmaceutical Ingredient (API) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Development & Scale-up Services
    • 4.5.1. Development & Scale-up Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Finished dose formulations
    • 4.6.1. Finished dose formulations Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Packaging
    • 4.7.1. Packaging Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Small Molecule Healthcare Contract Manufacturing Market: Therapeutic Area Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Small Molecule Healthcare Contract Manufacturing Market Therapeutic Area Movement Analysis
  • 5.3. Global Small Molecule Healthcare Contract Manufacturing Market Size & Trend Analysis, by Therapeutic Area, 2021 to 2033 (USD Million)
  • 5.4. Oncology
    • 5.4.1. Oncology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Cardiovascular Disease
    • 5.5.1. Cardiovascular Disease Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Neurological Disorders
    • 5.6.1. Neurological Disorders Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Infectious Diseases
    • 5.7.1. Infectious Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.8. Orthopedic Diseases
    • 5.8.1. Orthopedic Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.9. Metabolic Disorders
    • 5.9.1. Metabolic Disorders Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.10. Autoimmune Diseases
    • 5.10.1. Autoimmune Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.11. Gastrointestinal Disorders
    • 5.11.1. Gastrointestinal Disorders Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.12. Respiratory Diseases
    • 5.12.1. Respiratory Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.13. Ophthalmology
    • 5.13.1. Ophthalmology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.14. Dental Diseases
    • 5.14.1. Dental Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.15. Others
    • 5.15.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Small Molecule Healthcare Contract Manufacturing Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Small Molecule Healthcare Contract Manufacturing Market End Use Movement Analysis
  • 6.3. Global Small Molecule Healthcare Contract Manufacturing Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 6.4. Pharmaceutical Companies
    • 6.4.1. Pharmaceutical Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Biotechnology Companies
    • 6.5.1. Biotechnology Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Others
    • 6.6.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Small Molecule Healthcare Contract Manufacturing Market: Regional Estimates & Trend Analysis by Service, Service, End Use

  • 7.1. Regional Market Dashboard
  • 7.2. Global Regional Market Snapshot
  • 7.3. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
  • 7.4. North America
    • 7.4.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. UK Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competitive Scenario
      • 7.5.5.3. Regulatory Framework
      • 7.5.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Competitive Scenario
      • 7.5.6.3. Regulatory Framework
      • 7.5.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.7. Denmark
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.8. Sweden
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Competitive Scenario
      • 7.5.8.3. Regulatory Framework
      • 7.5.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.9. Norway
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Competitive Scenario
      • 7.5.9.3. Regulatory Framework
      • 7.5.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.5. Australia
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.6. South Korea
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Competitive Scenario
      • 7.6.6.3. Regulatory Framework
      • 7.6.6.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Competitive Scenario
      • 7.6.7.3. Regulatory Framework
      • 7.6.7.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8. Middle East & Africa
    • 7.8.1. Middle East & Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Competitive Scenario
      • 7.8.2.3. Regulatory Framework
      • 7.8.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Competitive Scenario
      • 7.8.3.3. Regulatory Framework
      • 7.8.3.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Competitive Scenario
      • 7.8.4.3. Regulatory Framework
      • 7.8.4.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Competitive Scenario
      • 7.8.5.3. Regulatory Framework
      • 7.8.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.6. Oman
      • 7.8.6.1. Key Country Dynamics
      • 7.8.6.2. Competitive Scenario
      • 7.8.6.3. Regulatory Framework
      • 7.8.6.4. Oman Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.7. Qatar
      • 7.8.7.1. Key Country Dynamics
      • 7.8.7.2. Competitive Scenario
      • 7.8.7.3. Regulatory Framework
      • 7.8.7.4. Qatar Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
    • 8.1.1. Market Leaders
    • 8.1.2. Emerging Players
  • 8.2. Small Molecule Healthcare Contract Manufacturing Market Position Analysis, 2024
  • 8.3. Company Profiles
    • 8.3.1. Lonza Group
      • 8.3.1.1. Company Overview
      • 8.3.1.2. Financial Performance
      • 8.3.1.3. Service Benchmarking
      • 8.3.1.4. Strategic Initiatives
    • 8.3.2. Catalent Inc.
      • 8.3.2.1. Company Overview
      • 8.3.2.2. Financial Performance
      • 8.3.2.3. Service Benchmarking
      • 8.3.2.4. Strategic Initiatives
    • 8.3.3. Recipharm AB
      • 8.3.3.1. Company Overview
      • 8.3.3.2. Financial Performance
      • 8.3.3.3. Service Benchmarking
      • 8.3.3.4. Strategic Initiatives
    • 8.3.4. Thermo Fisher Scientific Inc.
      • 8.3.4.1. Company Overview
      • 8.3.4.2. Financial Performance
      • 8.3.4.3. Service Benchmarking
      • 8.3.4.4. Strategic Initiatives
    • 8.3.5. WuXi AppTec
      • 8.3.5.1. Company Overview
      • 8.3.5.2. Financial Performance
      • 8.3.5.3. Service Benchmarking
      • 8.3.5.4. Strategic Initiatives
    • 8.3.6. Cambrex Corporation
      • 8.3.6.1. Company Overview
      • 8.3.6.2. Financial Performance
      • 8.3.6.3. Service Benchmarking
      • 8.3.6.4. Strategic Initiatives
    • 8.3.7. Eurofins Scientific
      • 8.3.7.1. Company Overview
      • 8.3.7.2. Financial Performance
      • 8.3.7.3. Service Benchmarking
      • 8.3.7.4. Strategic Initiatives
    • 8.3.8. Siegfried Holding AG
      • 8.3.8.1. Company Overview
      • 8.3.8.2. Financial Performance
      • 8.3.8.3. Service Benchmarking
      • 8.3.8.4. Strategic Initiatives
    • 8.3.9. CordenPharma
      • 8.3.9.1. Company Overview
      • 8.3.9.2. Financial Performance
      • 8.3.9.3. Service Benchmarking
      • 8.3.9.4. Strategic Initiatives
    • 8.3.10. PCI Pharma Services
      • 8.3.10.1. Company Overview
      • 8.3.10.2. Financial Performance
      • 8.3.10.3. Service Benchmarking
      • 8.3.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 North America Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 4 North America Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 5 North America Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 6 North America Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 7 US Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 8 US Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 9 US Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 10 Canada Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 11 Canada Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 12 Canada Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 13 Mexico Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 14 Mexico Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 15 Mexico Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 16 Europe Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 17 Europe Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 18 Europe Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 19 Europe Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 20 UK Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 21 UK Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 22 UK Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 23 Germany Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 24 Germany Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 25 Germany Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 26 France Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 27 France Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 28 France Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 29 Spain Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 30 Spain Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 31 Spain Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 32 Italy Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 33 Italy Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 34 Italy Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 35 Sweden Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 36 Sweden Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 37 Sweden Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 38 Norway Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 39 Norway Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 40 Norway Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 41 Denmark Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 42 Denmark Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 43 Denmark Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 44 Asia Pacific Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 45 Asia Pacific Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 46 Asia Pacific Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 47 Asia Pacific Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 48 Japan Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 49 Japan Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 50 Japan Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 51 China Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 52 China Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 53 China Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 54 India Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 55 India Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 56 India Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 57 Australia Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 58 Australia Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 59 Australia Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 60 Thailand Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 61 Thailand Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 62 Thailand Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 63 South Korea Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 64 South Korea Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 65 South Korea Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 66 Latin America Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 67 Latin America Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 68 Latin America Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 69 Latin America Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 70 Brazil Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 71 Brazil Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 72 Brazil Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 73 Argentina Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 74 Australia Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 75 Argentina Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 76 MEA Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 77 MEA Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 78 MEA Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 79 MEA Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 80 South Africa Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 81 South Africa Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 82 South Africa Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 83 Saudi Arabia Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 84 Saudi Arabia Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 85 Saudi Arabia Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 86 UAE Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 87 UAE Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 88 UAE Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 89 Kuwait Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 90 Kuwait Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 91 Kuwait Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 92 Oman Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 93 Oman Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 94 Oman Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 95 Qatar Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 96 Qatar Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 97 Qatar Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Small Molecule Healthcare Contract Manufacturing Market Segmentation
  • Fig. 2 Market Research Process
  • Fig. 3 Information Procurement
  • Fig. 4 Primary Research Pattern
  • Fig. 5 Market Research Approaches
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Commodity Flow Analysis
  • Fig. 8 Value-Chain-Based Sizing & Forecasting
  • Fig. 9 QFD Model Sizing & Forecasting
  • Fig. 10 Bottom-up Approach
  • Fig. 11 Market Snapshot
  • Fig. 12 Segment Snapshot
  • Fig. 13 Segment Snapshot
  • Fig. 14 Segment Snapshot
  • Fig. 15 Competitive Landscape Snapshot
  • Fig. 16 Parent Market Outlook, 2024 (USD Million)
  • Fig. 17 Ancillary Market Outlook, 2024 (USD Million)
  • Fig. 18 Small Molecule Healthcare Contract Manufacturing Market Dynamics
  • Fig. 19 Total R&D Drug Pipeline Size, 2021-2024
  • Fig. 20 Porter's Five Forces Analysis
  • Fig. 21 PESTEL by SWOT Analysis
  • Fig. 22 Small Molecule Healthcare Contract Manufacturing Market Service outlook: Segment dashboard
  • Fig. 23 Small Molecule Healthcare Contract Manufacturing Market, by Service Segment: Market Share, 2025 & 2033
  • Fig. 24 Active Pharmaceutical Ingredient (API) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Development & Scale-up Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Finished dose formulations Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Packaging Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Small Molecule Healthcare Contract Manufacturing Market Therapeutic Area outlook: Segment dashboard
  • Fig. 29 Small Molecule Healthcare Contract Manufacturing Market, by Therapeutic Area Segment: Market Share, 2025 & 2033
  • Fig. 30 Oncology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Cardiovascular Disease Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Neurological Disorders Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Infectious Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Orthopedic Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Metabolic Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Gastrointestinal Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Respiratory Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Ophthalmology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Dental Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Small Molecule Healthcare Contract Manufacturing Market End Use Outlook: Segment Dashboard
  • Fig. 42 Small Molecule Healthcare Contract Manufacturing Market, by End Use Segment: Market Share, 2025 & 2033
  • Fig. 43 Pharmaceutical Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Biotechnology Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 Regional marketplace: Key Takeaways
  • Fig. 47 North America Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Key country dynamics
  • Fig. 49 US Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 Key country dynamics
  • Fig. 51 Canada Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Key country dynamics
  • Fig. 53 Mexico Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Europe Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Key country dynamics
  • Fig. 56 UK Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 Germany Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 France Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 Italy Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 Spain Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 Denmark Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 Norway Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 69 Key country dynamics
  • Fig. 70 Sweden Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 71 Asia Pacific Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 Japan Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 China Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 India Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 78 Key country dynamics
  • Fig. 79 Australia Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 80 Key country dynamics
  • Fig. 81 South Korea Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 82 Key country dynamics
  • Fig. 83 Thailand Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 84 Latin America Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 85 Key country dynamics
  • Fig. 86 Brazil Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 87 Key country dynamics
  • Fig. 88 Argentina Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 89 MEA Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 90 Key country dynamics
  • Fig. 91 South Africa Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 92 Key country dynamics
  • Fig. 93 Saudi Arabia Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 94 Key country dynamics
  • Fig. 95 Kuwait Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 96 Key country dynamics
  • Fig. 97 UAE Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 98 Key country dynamics
  • Fig. 99 Oman Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 100 Key country dynamics
  • Fig. 101 Qatar Small Molecule Healthcare Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 102 Market Participant Categorization
  • Fig. 103 Heat Map Analysis